Bevacizumab is associated with cerebral microstructural alterations: a DTI study in high-grade glioma

BACKGROUND: For recurrent high-grade glioma, especially glioblastoma, no standard of care treatment exists. Due to the prolongation of progression-free survival and a cortiocosteroid-sparing effect, bevacizumab is often used in this condition. Despite initial clinical responses, there is growing evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassubek, Rebecca, Lulé, Dorothée, Ludolph, Albert C., Kassubek, Jan, Müller, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247958/
https://www.ncbi.nlm.nih.gov/pubmed/37305747
http://dx.doi.org/10.3389/fneur.2023.1191226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247958/
https://www.ncbi.nlm.nih.gov/pubmed/37305747
http://dx.doi.org/10.3389/fneur.2023.1191226

Ejemplares similares